Hepatocyte growth factor as a potential index of complication in diabetes mellitus
Shigefumi Nakamura(The University of Osaka), Toshio Ogihara(The University of Osaka), Yoshikage Yo(The University of Osaka), Toshikazu Nakamura(The University of Osaka), Shinichiro Hayashi(The University of Osaka), Kunio Matsumoto(Kanazawa University), Keiko Matsumoto(Kagawa University), Atsushi Moriguchi(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Yoshio Nakamura(Tokyo Institute of Technology), Ryuichi Morishita(The University of Osaka)
Cited by 44
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
|Proceedings of the National Academy of Sciences|2010|501